Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05640908 · ClinicalTrials.gov registry record
Pelvic Fixation and Fusion During Multilevel Spinal Surgery
A clinical trial of Spinal Fusion and Deformity of Spine, sponsored by SI-BONE.
- Active
- Registry status
- 200
- Enrollment target
- 9
- Study locations
NCT05640908: Active study of Spinal Fusion and Deformity of Spine, sponsored by SI-BONE.
NCT05640908 is a study of Spinal Fusion and Deformity of Spine that is active but no longer recruiting, run by SI-BONE. The registered enrollment target is 200 participants, below the 473-participant average among 19 other Spinal Fusion trials with a reported enrollment target (58% lower). The trial reports 9 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05640908, a study of Spinal Fusion and Deformity of Spine, is active but no longer recruiting, sponsored by SI-BONE.
- ACTIVE NOT RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 9
- Study locations
Study Summary
PAULA aims to collect data on the safety, performance, and effectiveness of iFuse Bedrock Granite (GRANITE) in patients who have spinal fusion surgery with pelvic fixation/ fusion.
Conditions Studied
Interventions
- DEVICE iFuse Bedrock Granite Implant System
Study Locations (9)
New York
- University at Buffalo - Buffalo
- Northwell Health - New York
Texas
- University of Texas Health, Houston - Houston
- Texas Back Institute - Plano
Alabama
- USA Neurosurgery - Mobile
Colorado
- University of Colorado School of Medicine - Aurora
Michigan
- Corewell Health - Royal Oak
Minnesota
- University of Minnesota - Minneapolis
North Carolina
- Pinehurst Surgical Clinic - Pinehurst
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-06-05 |
| Est. Completion | 2027-12 |
What the registry record for NCT05640908 still lists
NCT05640908 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 473-participant average among 19 other Spinal Fusion trials with a reported enrollment target (58% lower).
The record links to 2 conditions, with Spinal Fusion appearing as the primary indexed condition, and to 1 intervention - of which iFuse Bedrock Granite Implant System is the first listed.
NCT05640908 lists 9 locations in 7 states (New York, Texas, Alabama).
Frequently Asked Questions
What is clinical trial NCT05640908 about?
NCT05640908 is a clinical study titled "Pelvic Fixation and Fusion During Multilevel Spinal Surgery". PAULA aims to collect data on the safety, performance, and effectiveness of iFuse Bedrock Granite (GRANITE) in patients who have spinal fusion surgery with pelvic fixation/ fusion.
What is the current status of trial NCT05640908?
This trial is currently active not recruiting. The enrollment target is 200 participants. The study started on 2023-06-05. Estimated completion is 2027-12.
What conditions does trial NCT05640908 study?
This clinical trial studies the following conditions: Spinal Fusion, Deformity of Spine.
What interventions are being tested in trial NCT05640908?
The interventions under investigation include: iFuse Bedrock Granite Implant System (DEVICE).
Who is sponsoring clinical trial NCT05640908?
This trial is sponsored by SI-BONE, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05640908 being conducted?
This trial has 9 study locations across Alabama, Colorado, Michigan, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Fusion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05640908's enrollment target sits among peer trials
200 7th of 19 higher than 13 of 19 other Spinal Fusion trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Fusion trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain
RECRUITING · Phase 3
-
Pulse-Width Modulation
RECRUITING · NA
-
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
RECRUITING · Phase 2
-
Durability of Suppl. Rod Constructs-SuppleMentAry Rod Technique for Long-segment Posterior Instrumented Spinal Fusions
RECRUITING
-
Photobiomodulation for Lower Back Pain Post Spinal Fusion and Decompression Surgery
RECRUITING · NA
-
Kids With Iron Deficiency and Scoliosis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI